We are pleased to report that Housden Group’s Director and Principal Consultant, Philip Housden has joined Check4Cancer‘s board as a non-executive director.
Philip brings considerable experience to the role – he has over 30 years of experience in the public and private healthcare sector and has particular expertise in health economies, commercial options, clinical and strategic solutions.
Professor Gordon Wishart, CEO and CMO at Check4Cancer, said: ‘I am delighted that Philip has accepted our invitation to join the Board as a NED and we look forward to working closely with him as we grow our portfolio of cancer services”
Philip said: “I’m thrilled to be taking up a non-executive director role with Check4Cancer. It plays a vital role in the provision of early cancer detection and genetic services in the UK and I’m delighted to be able to contribute my expertise and interests to the Board to help secure its continued success.”